A national leader in Alzheimer’s care
A major success of the Canadian IMPACT-AD study was the launch, in 2021, of the national Alzheimer's disease biomarker testing program....
top of page
Search
- Feb 17, 2023
Understanding frontotemporal dementia
IMPACT-AD study investigator Dr. Robin Hsiung talks about frontotemporal dementia on the Global TV News Health Matters series....
- Feb 1, 2023
Perspectives on testing from persons with lived experience
Dementia Dialogue
- Jan 24, 2023
Alzheimer Society webinar on biomarker testing
Join us January 25, 2023 at 2 pm pacific time for a webinar on Alzheimer's disease biomarker testing hosted by the Alzheimer Society of...
- Dec 26, 2021
Who, what, where & when of Alzheimer's testing
Talking with podcaster Real Talk Ryan Jespersen about the new Canadian Alzheimer's disease biomarker testing program based at St. Paul's...
- Dec 25, 2021
First-in-Canada testing program for Alzheimer’s
On July 1, 2021 the St. Paul's Hospital Clinical Laboratory in Vancouver launched the Alzheimer's disease biomarker testing program for...
- Nov 30, 2021
Biomarker testing guides in multiple languages
Want to learn more about the biomarkers involved in Alzheimer's disease testing, and how cerebrospinal fluid is collected? Check out our...
- Jun 30, 2020
Alzheimer's disease testing innovation
The IMPACT-AD team's Alzheimer's disease testing innovation for amyloid-beta proteoforms has been published in a leading scientific...
- May 31, 2020
2020 Alzheimer Update
At the 2020 Alzheimer Update, Dr. DeMarco and Dr. Hsiung discuss biomarker testing and therapies for Alzheimer's disease....
- Nov 30, 2019
Dr. Stites talks to the New York Times about early diagnosis
"A diagnosis explains what's happening, why you're not remembering" In this interview, Dr. Stites talks about reducing the stigma around...
- Dec 31, 2018
Changing the future for people affected by dementia
The Alzheimer Society of British Columbia interviews Dr. DeMarco about the development of diagnostic tests for Alzheimer's....
- Oct 4, 2018
Brain Canada & Health Canada fund the IMPACT-AD study!
The IMPACT-AD ("Translating research into practice: Investigating the impact of Alzheimer's disease diagnostics in Canada") Study was...
bottom of page